NPI: 1265711956 · LINCOLNTON, NC 28092 · Pediatric Sports Medicine Physician · NPI assigned 08/11/2011
Authorized official RISSMILLER, SCOTT controls 20+ related entities in our dataset. Read more
| Authorized Official | RISSMILLER, SCOTT (ENTERPRISE EVP) |
| Parent Organization | CAROLINAS PHYSICIANS NETWORK INC |
| NPI Enumeration Date | 08/11/2011 |
Other providers sharing the same authorized official: RISSMILLER, SCOTT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,578 | $303K |
| 2019 | 11,517 | $386K |
| 2020 | 12,056 | $377K |
| 2021 | 25,043 | $596K |
| 2022 | 40,006 | $765K |
| 2023 | 42,661 | $721K |
| 2024 | 42,841 | $693K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14,258 | 11,502 | $843K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8,996 | 7,463 | $805K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6,291 | 5,094 | $503K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5,364 | 4,324 | $439K |
| 99199 | Unlisted special service, procedure or report | 68,715 | 44,523 | $360K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 5,101 | 4,217 | $174K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 7,538 | 6,246 | $134K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2,564 | 2,336 | $132K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,139 | 1,013 | $105K |
| D0145 | Oral evaluation for a patient under three years of age | 1,846 | 1,609 | $60K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 10,110 | 8,650 | $47K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 759 | 685 | $46K |
| 99215 | Prolong outpt/office vis | 274 | 228 | $34K |
| 90474 | 1,877 | 1,602 | $34K | |
| D1206 | Topical application of fluoride varnish | 1,842 | 1,606 | $27K |
| 96127 | 4,819 | 4,136 | $19K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,186 | 1,014 | $14K |
| 83655 | 1,032 | 806 | $13K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 76 | 66 | $7K |
| 90677 | 690 | 684 | $7K | |
| 99381 | 70 | 50 | $6K | |
| 96161 | 1,734 | 1,547 | $5K | |
| 85027 | 849 | 636 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 95 | 88 | $5K |
| 87807 | 278 | 227 | $4K | |
| 92551 | 3,097 | 2,696 | $3K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 14 | 12 | $2K |
| 54150 | 14 | 13 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 560 | 464 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 183 | 116 | $1K |
| 99173 | 3,117 | 2,733 | $747.73 | |
| 88720 | 162 | 82 | $692.61 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 19 | 15 | $682.06 |
| 90686 | 2,029 | 1,765 | $496.96 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 14 | 13 | $423.66 |
| 85018 | 568 | 482 | $412.57 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 84 | 70 | $287.40 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 15 | 14 | $165.99 |
| 81003 | 55 | 45 | $101.75 | |
| 1160F | 3,125 | 2,724 | $96.19 | |
| 1159F | 5,001 | 4,040 | $96.19 | |
| 90633 | 1,383 | 1,117 | $89.84 | |
| 90656 | 216 | 202 | $41.02 | |
| 99177 | 116 | 104 | $36.54 | |
| 90672 | 13 | 13 | $23.64 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 163 | 101 | $4.37 |
| 90723 | 3,212 | 2,798 | $2.36 | |
| 90647 | 3,181 | 2,728 | $0.00 | |
| 3008F | 648 | 612 | $0.00 | |
| 90680 | 2,758 | 2,398 | $0.00 | |
| 3074F | 1,415 | 1,155 | $0.00 | |
| 90716 | 824 | 672 | $0.00 | |
| 90651 | 12 | 12 | $0.00 | |
| 90696 | 19 | 15 | $0.00 | |
| 94760 | 43 | 36 | $0.00 | |
| 36416 | 21 | 13 | $0.00 | |
| 3078F | 1,381 | 1,125 | $0.00 | |
| 90670 | 3,759 | 3,172 | $0.00 | |
| 90707 | 812 | 658 | $0.00 | |
| G9919 | Screening performed and positive and provision of recommendations | 77 | 63 | $0.00 |
| 90700 | 89 | 77 | $0.00 |